A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

Research tells us that eating enough protein and staying physically active can be helpful in reducing the amount of non-fat ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The big pharma companies Novo Nordisk and Eli Lilly look to be the main ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Studies have suggested that the Mediterranean diet is more sustainable long-term than the ketogenic diet. No one diet is best for people with diabetes because people are not all the same. Because of ...

Instead, metformin may cause weight loss. Thiazolidinediones are another class of drugs used to treat type 2 diabetes ... What is the best insulin-sensitizing medication? The best insulin ...